Cancer Genet Cytogenet 1999, 111: 134–138.PubMedCrossRef 28. Hinze R, Schagdarsurengin U, Taubert H, Meye A, Wurl P, Holzhausen HJ, Rath FW, Schmidt H: Assessment of genomic imbalances in malignant fibrous histiocytomas
by comparative genomic hybridization. Int J Mol Med 1999, 3: 75–79.PubMed 29. Weng WH, Ahlen J, Lui WO, Brosjo O, Pang ST, Von Rosen A, Auer G, Larsson O, Larsson C: Gain of 17q in malignant fibrous histiocytoma is associated with a longer disease-free survival and a low risk of developing distant metastasis. Br J Cancer 2003, 89: 720–726.PubMedCrossRef 30. Carneiro A, Francis P, Bendahl PO, Fernebro J, Akerman M, Fletcher C, Rydholm A, Borg A, Nilbert M: Indistinguishable genomic profiles and shared prognostic markers in undifferentiated pleomorphic sarcoma and leiomyosarcoma: SC79 order different sides of a single coin? Lab Invset 2009, 89: 668–675.CrossRef
31. Tarkkanen M, Larramendy ML, Bohling T, Serra M, Hattinger CM, Kivioja A, Elomaa I, Picci P, Knuutila S: Malignant fibrous histiocytoma of bone: analysis of genomic imbalance by comparative genomic hybridization and C-MYC expression by immunohistochemistry. Eur J Cancer 2006, 42: 1172–1180.PubMedCrossRef 32. Cho YL, Bae S, Koo MS, Kim KM, Chun HJ, Kim CK, Ro DY, Kim JH, Lee CH, Kim YW, Ahn WS: Array comparative genomic hybridization analysis of uterine leiomyosarcoma. Gynecol Oncol 2005, 99: 545–551.PubMedCrossRef 33. Artavanis-Tsakonas S, Matsuno K, Fortini ME: Notch signaling. Science 1995, 268: 225–232.PubMedCrossRef 34. Akt inhibitor Engin F, Bertin T, Ma O, Jiang MM, Wang L, Sutton RE, Donehower LA, Lee B: Notch signaling contributes to the pathogenesis of human osteosarcomas. Hum Mol Genet 2009, 18: 1464–1470.PubMedCrossRef 35. Franchi A, Santucci M: Tenascin expression in cutaneous fibrohistiocytic tumors. Immunohistochemical investigation of 24 cases. Am J Dermatopathol 1996, 18: 454–459.PubMedCrossRef 36. Kim WY, Sharpless NE: The regulation of INK4/ARF in cancer and aging. Cell 2006, 127: 265–275.PubMedCrossRef 37. Simons A, Schepens M, Jeuken J, Sprenger S, van de Zande G, Bjerkehagen B, Forus A, Weibolt V, Molenaar I, van de
Berg E, Myklebost O, Bridge isothipendyl J, van Kessel AG, Suijkerbuijk R: Frequent loss of 9p21 ( p16 INK4A ) and other genomic imbalances in human malignant fibrous histiocytoma. Cancer Genet Cytogenet 2000, 118: 89–98.PubMedCrossRef Competing interests The authors declare that they have no competing interests. Authors’ contributions JN conceived the study and click here drafted the manuscript. JN and MI carried out the experimental work. TI managed the patient. HI, KN, TI, and MN participated in the design of the study and evaluated the manuscript. All authors read and approved the final manuscript.”
“Introduction Gene therapy holds great promise for the treatment of cancer diseases. Successful gene therapy requires safe and efficient delivery systems [1].